Delivery Order 75N93021D00010-75N93021F00003
Award Date
9/1/21
Potential Completion Date
8/31/25
Potential Value
$289K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Southern Research Institute
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Birmingham, AL 35205, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS). The $254,076.51 cost-plus-fixed-fee delivery order contract was awarded to Southern Research Institute, a non-profit organization that provides advanced drug discovery and development services. The contract supports high-throughput screening to identify HIV inhibitors as part of NIAID's "In Vitro Testing...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Southern Research Institute, a non-profit research organization. The $257,889.11 cost-plus-fixed-fee contract is for the identification of anti-HIV lead compounds, which is part of NIAID's "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" program. The contract has no set-aside designation and is a...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS). The $496,282.56 cost-plus-fixed-fee contract was awarded to Southern Research Institute to identify anti-HIV therapeutics and topical microbicides through in vitro testing. The contract is part of NIAID's "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" program and does not have a...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Southern Research Institute, a nonprofit research organization. The contract is for the "Identification of Lead Compounds to Inhibit HIV-1 Regulatory Proteins" and has a ceiling value of $516,565. This is a cost-plus-fixed-fee delivery order contract, without a set-aside designation. Southern Research Institute holds...
This is a Cost Plus Fixed Fee federal delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Southern Research Institute, a non-profit research organization. The $249,997 contract is for the identification of anti-HIV lead compounds as part of NIAID's in vitro testing resource for HIV therapeutics and topical microbicides. Southern Research Institute, which holds multiple federal indefinite...
This is a cost-plus-fixed-fee Delivery Order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Southern Research Institute, a non-profit research organization, with a potential value of $146,812.16. The contract is for the contractor to test interventional agents in laboratory and specialized assays with the objective of identifying and characterizing at least one agent with activity. This...
This federal contract, awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases, tasks Southern Research Institute with testing interventional agents in confirmatory and specialized assays to identify and characterize agents with activity to block HIV infection, inhibit HIV gene expression and replication, or cure infected cells of HIV infection. The contract, which has a potential value of $174,999.00, does not have a set-aside designation and was...
This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit organization. The $684,610.00 contract is for the identification of anti-HIV therapeutics and topical microbicides, which falls under NIAID's "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" major program. The contract has a...
This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit organization. The contract, valued at $275,547.00, is a delivery order under a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle for providing preclinical services related to the development of HIV therapeutics and topical microbicides. The work to be performed under...
The Southern Research Institute has been awarded a $12,640.21 delivery order against the Preclinical Services for HIV Therapeutics master IDIQ contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Under this cost-plus-fixed-fee task order, Southern Research will develop and deliver a quality assurance/quality control plan and participate in a task order initiation meeting to support preclinical services for HIV therapeutics. The work will be...